InvestorsHub Logo
Followers 264
Posts 18604
Boards Moderated 0
Alias Born 01/19/2006

Re: DMC8 post# 436284

Saturday, 06/07/2025 11:55:27 PM

Saturday, June 07, 2025 11:55:27 PM

Post# of 437285
As to how and why CVS is back with AMRN Vascepa preferred, and generics are excluded, maybe the following factors play a part. An update from me:

1) FedEx notified us, 5/21/2025, that a 3.5 lb package of documents had been delivered to the FDA OCI in Beltsville, Md
2) FedEx notified us, 5/21/2025, that a 3.5 lb package of documents had been delivered to the FDA Commisioner, Silver Spring, Md
3) FedEx notified us,  5/21/2025, that a 3.5 lb package of documents had been delivered to the FTC Chairman, Washington, D.C.
4) On ~ 6/4/2025, a 3.5 lb package of documents was shipped to the Solicitor General, Washington, D.C., delivery on 6/5/2025. We arrived in Philadelphia on 6/6/2025 for birthday of friend, return home tomorrow, 6/8/2025.
In brief, each of above included a 5-page summary letter of the package of documents, followed by a) photocopies of the entire AMRN shareholder Petition for Writ of Certiorari, b) a notation that no Court in the Federal Judiciary had rendered a judgment accompanied by a rational opinion discussing the evidence of two generics' fraud set forth in the Petition, c) a full photocopy of Hazel-Atlas, 322 U.S. 238(1944), d) a paragraph comparing the fraud on the Courts in Hazel-Atlas, 322 U.S. at 240-243, with the fraud on the Courts set forth in the above Petition,I.e., fabricated evidence and pages 61A-62A of the Petition, e) a paragraph observing that 2 generics had not asked the Nevada District Court to correct her opinion as mistaken with resulting opinion that lack of such action led to conclusion of a deliberate intent to deceive the Courts, and f) a paragraph describing OCI's existence coupled with opinion that FDA Commissioner should withdraw approval of both generics' ANDAs in light of above fraud, consistent with FDA Compliance Policy Guide(CPG) 120.100, Hazel-Atlas, and progeny of 18 U.S.C. 1001, g)  a photocopy of  104 F. 4th, h) photocopies of Hikma's Petition for Writ of Certiorari filed 2/2025 together with Amarin's Oppostion filed 5/15/2025 and Hikma 6/2025 reply. 

We have NO information whether any Federal agencies have acted in any manner pursuant to information they received above. We will explore further on our return home, likely tomorrow.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News